Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 858 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 602 days ago
Sensex, Nifty Marginally Lower In Early Trade

Sensex, Nifty Marginally Lower In Early Trade

Indian shares struggled for direction on Tuesday as tensions between India and Pakistan simmered and media reports suggested that India has proposed zero tariffs on steel, auto components and pharmaceuticals on a reciprocal basis up to a certain quantity of imports in its trade negotiations with the U.S.
RTTNews | 20 minutes ago
Australian Market Slightly Higher In Mid-market After Early Losses

Australian Market Slightly Higher In Mid-market After Early Losses

The Australian stock market is slightly higher in mid-market trading on Tuesday after early losses, reversing some of the losses in the previous session, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,200 level, with strong gains in gold miners nearly offset by weakness in iron ore miners, financial and some technology stocks.
RTTNews | 37 minutes ago
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Tuesday, despite the broadly negative cues from Wall Street overnight, amid easing global trade concerns after US Treasury Secretary Scott Bessent said 17 trading partners, excluding China, have presented very good trade proposals and some deals may be announced as early as this week. He added there could be substantial progress on trade with China.
RTTNews | 1h 21min ago
Thai Stock Market Due For Consolidation On Tuesday

Thai Stock Market Due For Consolidation On Tuesday

Ahead of Monday's holiday for Coronation Day, the Thai stock market had moved higher in five straight sessions, gathering more than 50 points or 4.2 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,200-point plateau although it's expected to open in the red on Tuesday.
RTTNews | 2h 21min ago